Use CaseR and DPharma & Biotech / Pharma & Biotech

Identify and validate a molecule to target with a drug compound

During the initial phase of drug research and development, the target for a new drug treatment must first be chosen. The target molecule will be what the drug compound interacts with to get the intended outcome, often the treatment of a disease.

Cost

Cost - Targeted Trials/ Precision testing

Cost

Cost - Reduce wastage

Linked Case Studies

Case Study

BERG

BERG is attempting to identify genetic predisposition to certain conditions using machine learning with promising Phase I study results

→

Case Study

GlaxoSmithKline

GlaxoSmithKline (GSK) plans to reduce drug discovery to trial time from six years to 12 months using machine learning models to predict molecular behaviour

→

Case Study

Ecole Polytechnique Fédérale de Lausanne (EPFL)

Researchers at EPFL predict chemical shifts of molecular solids and their polymorphs to within DFT accuracy with machine learning

→

Case Study

University of Lisbon

Researchers at University of Lisbon accelerate drug discovery with the use of machine learning

→

Case Study

BERG

BERG is developing targeted cancer drugs using machine learning with promising Phase I study results

→

←Back to Use Case Library

Editor: sdg